"Lewy Body Dementia Awareness Month is an important opportunity to raise awareness of this underdiagnosed but prevalent condition that can be devastating for patients and their loved ones," said ...

What to expect as the condition progressesMedically reviewed by Smita Patel, DOLewy body dementia (LBD) is a type of dementia ...

The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with ...

Other causes may include vascular dementia, Lewy body dementia, brain injuries, and certain underlying health conditions. Major neurocognitive disorder, also known as dementia, is a ...

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Lewy bodies ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can ...

Patient characteristics are consistent with other DLB studies -PURCHASE, N.Y., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, ...

"Lewy Body Dementia Awareness Month is an important opportunity to raise awareness of this underdiagnosed but prevalent condition that can be devastating for patients and their loved ones," said Lisa ...

In the phase 2 study, 43 adults with DLB were randomly assigned to receive 200 mg of oral nilotinib or matching placebo for 6 ...